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Abstract— Despite 60 years of research into necrotising 
enterocolitis (NEC), our understanding of the disease has not 
improved enough to achieve better outcomes. Even though 
NEC has remained the leading cause of death and poor 
outcomes in preterm infants, there remain vital questions on 
how to define, differentiate and detect the condition. Numerous 
international groups have recently highlighted NEC as a 
research priority and called for broader engagement of the 
scientific community to move the field forward. The three 
foremost barriers at present are lack of suitable definition(s), 
lack of clean datasets and consequently a lack of scope to gain 
sufficient insights from data. This research paper proposes a 
new direction of travel to advance neonatal gastro-intestinal 
monitoring and strengthen our efforts to gain better insights 
from global databases. An integrated machine learning based 
model is recommended to produce a comprehensive disease 
model to manage the complexity of this multi-variate disease. 
This intelligent disease model would be used in the daily 
neonatal settings to help aggregate data to support clinical 
decision making, better capture the complexity of each patient 
to enrich global datasets to create bigger and better data. This 
paper reviews current machine learning and CAD technologies 
in neonatology and suggests an innovative approach for an 
NEC disease model.   
Keywords— Machine Learning, Necrotising Enterocolitis, 
NEC, Big Data, AI Based Diagnosis, Predictive Modelling, 
Multi-Variate Analysis, Deep Learning, Ensemble Modelling, 
Computer Assisted Detection, Disease Model. 
I. INTRODUCTION: THE CHALLENGE OF NEC 
Necrotizing enterocolitis (NEC) is considered the most 
devastating gastrointestinal emergency in the neonatal unit. It 
has remained a significant cause of neonatal death and poor 
developmental outcomes with a mortality of up to 60% [1]. 
Extensive research has been performed to understand NEC 
better, but despite these efforts, it remains an elusive disease 
to diagnose and differentiate from other Acquired Neonatal 
Intestinal Diseases (ANID) [2].  
Acquired Neonatal Intestinal Diseases (ANID) is a group 
of conditions that are complex multi-variate conditions that 
are difficult to delineate, detect and diagnose. Of concern, is 
the disease course of ANID conditions such as SIP and NEC 
as they can be unpredictable and can rapidly progress to 
peritonitis and shock. Highlighting the urgent need for non-
invasive, readily available and dynamic computer-aided 
detection support in clinical practice. ANID research also 
lacks a structure to uniformly capture the complexities of a 
patient’s presentation in its entirety to recreate rich data sets 
that can globally be aggregated to create big data for 
research.  
Timely diagnosis and monitoring is an important focus 
area for current NEC research as it can improve outcomes 
[2]. In current practice, the diagnosis of SIP and NEC is 
made based on clinical findings, laboratory investigations 
and medical imaging. The diagnosis strongly relies on 
imaging, as it provides an objective measurement to move 
beyond suspected NEC (suggestive clinical findings) to 
medically confirm NEC. However, imaging interpretation 
can also be challenging showing great inter-expert 
variability, as nonspecific results do not preclude NEC 
entirely [3]. There is currently no computer-aided detection 
software (CAD) for abdominal radiographs (AR) or 
abdominal ultrasound (AUS) in neonates. Newer imaging 
modalities such as AUS has excellent potential to outperform 
AR but unfortunately is underutilised. The use of AUS has 
been mainly limited to when AR findings are inconclusive. 
This is despite AUS showing several advantages over AR 
and outperforming AR in diagnosing NEC [4]. 
It is unlikely that traditional clinical research methods 
will progress NEC research as rapidly as machine learning 
(ML) and CAD enabled technology can. Although a 
randomised control trial is still considered the golden 
standard for univariate research to determine causality, 
observational trials as a research methodology have received 
renewed interest due to advanced analytic technologies being 
powerful enough for multivariable processing and 
management of confounders. Using real-world evidence 
(RWE), neonatology can overcome uncertainties about 
benefits, risk, real-life utilisation and performance of 
biomarkers or new therapies [5]. Obstetrics and Neonatology 
have limited ethical scope in trials approval, further 
advocating for insights from databases. ML can enable richer 
extraction of data, overcome bias (as it offers more objective 
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processing) and lead to the extraction of better insights [6]. 
Furthermore, it is also able to cleanse existing databases of 
non-NEC entities, therefore improving the quality of current 
databases. 
II. GAINING INSIGHTS THROUGH PREDICTIVE MODELING OF 
CLINICAL PRESENTATION 
A. Differentiating NEC from other ANID’s clinical features 
The most common three forms of the Acquired neonatal 
intestinal disease (ANID) is: spontaneous intestinal 
perforations (SIP), classic necrotising enterocolitis (Preterm 
NEC) and Term-NEC (primarily seen in term infants) [7]. 
See Table I for their differential features. 
TABLE I.  DIFFERENTIAL FEATURES FOR THREE COMMON FORMS 
OF ANID [7]. 
Spontaneous 
Intestinal Perforation 
Preterm NEC Term NEC 
Onset of symptoms:  
Birth weight< 1250g: 
onset within first seven 
days.   
Birth weight> 1250g: 
onset within two 
weeks. 
 
Onset of symptoms:  
Onset usually after two 
weeks.  
In cases that are 
ischemia-driven, onset 
is within first month of 
life.  
Onset of symptoms:  
Onset within the first 
month of life, often 
within 11-25 days. 
Gestational age:  
Most cases of SIP 
involve infants < 30 
weeks gestation and 
<1500g.  
Older infants often 
have  IUGR 
 
Gestational age:  
<36 weeks gestation 
 
Gestational age:  
≥36 weeks gestation 
Clinical Features: 
Insidious onset of 
symptoms.  
In most cases affects 
low birth weight 
(<1500g) with  <30 
weeks gestation. 
Abdominal distention  
Blue-grey 
discolouration of the 
abdominal wall.  
No enteral feeding 
association. 
. 
Clinical Features: 
Abdominal distention, 
ileus and/or blood in 
stools. 
Persistent platelet 
consumption 
Meets “Two out of 
Three” rule* 
Requires three 
preconditions: 
A. Naive bowel, food 
in the bowel. 
B. Trigger event. 
C. Fits Sartwell’s 
model of disease onset. 
 
Clinical Features: 
Abdominal distention, 
ileus and/or bloody 
stools. 
Birth weight greater 
than 2500g.  
Associated maternal 
illicit drug use, 
intestinal anomalies 
and congenital heart 
disease. 
Imaging Features: 
AUS or AR 
visualisation of 
Pneumoperitoneum 
without pneumatosis. 
 
Imaging Features: 
AUS or AR 
visualisation of 
Portal Venous Gas 
(PVG) or Pneumatosis 
Intestinalis (PI). 
 
Imaging Features: 
AUS or AR 
visualisation of 
Portal Venous Gas 
(PVG) or Pneumatosis 
Intestinalis (PI). 
 
B. The rationale for CAD insights to improve clinical 
decision making. 
Clinicians are faced with ever-increasing demands on 
their time and expected to evaluate information across 
systems to extract insights to provide recommendations 
continually and quickly throughout the day. This requires the 
ongoing data collection and aggregation to assess the infant. 
Various cognitive shortcuts can develop, unknowingly. 
These paradigms are timesaving strategies, to enable the 
clinician to meet an ever-increasing workload. 
Unfortunately, as various cognitive biases develop, this can 
result in clinicians making assumptions that are often only 
seen in retrospect. 
By enabling CAD, it can work as the clinicians assistant 
in aggregating data and summarise findings. This can save a 
significant amount of time, free cognitive processing 
capacity to make more thorough enquiry of the summarised 
data and utilise more energy on patient care planning. 
Furthermore, as CAD does not rely on biased experience and 
didactics, more productive and more uniform data is created 
that can readily be aggregated to international databases.  
C. Predictive modelling trials relevant to NEC 
 Predictive modelling of NEC’s clinical features would 
utilise data from, but is not limited to, clinical findings, 
assessment scores, lab results and clinical outcomes (see 
Figure 1). It needs to be appreciated that some data varies 
from static (binary) to dynamic values (example respiratory 
status). The current guidance case definitions and differential 
features (as provided in Table I) should form the foundation 
to formulate the supervised machine learning model. 
Collaboration with systems researchers, clinicians and 
radiologists would be needed ongoing insight and final 
approval of results. Techniques in building a supervised 
model are very diverse in the literature and would require 
ongoing comparative assessments against standardised 
techniques versus an ensemble model to accomplish the 
highest area under the curve (AUC). 
FIGURE 1: OVERVIEW OF SUITABLE NEC DATA SOURCES AND VARIOUS 
MACHINE LEARNING TECHNIQUES SUITABLE TO BUILD A PREDICTION 
MODEL. 
 
 Figure 1 shows several such examples of how modelling 
could be approached. Of note these trials do deploy various 
techniques simultaneously of supervised and unsupervised 
models, again showing the heterogeneous nature of 
modelling. These are, but are not limited to, Support Vector 
Regressor (SVR), Support Vector Machines (SVM); - 
Gaussian Processes Regression (GPR); Generalized linear 
model GLM and Fuzzy c-means (FCM). In the next section 
focus will be to elaborate on ML and Deep Learning trials in 
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NEC or those that show promise in building a collective 
disease model (Figure 2). 
Information can be extracted from neonatal electronic 
medical records (EMR) using classification models such as 
Support Vector machines and Naives Bayes. A recent 
systematic review looking into ML classification techniques 
[8], recommended extensive tuning of classification 
parameters. Recommending further refining of the impact of 
kernel type, adding or removing Gaussian mutation, gamma 
value, epsilon value, participant numbers, and C in SMV. In 
the case of Naïve Bayes classification, the smoothing values 
and baseline class weighing needed careful consideration to 
refine. Cohen et al. 2016, in his HER extraction only 
optimised only kernel type, C, and gamma to improve 
accuracy [9]. His study also highlighted that careful 
consideration should be given to training database size, 
feature selection, classification technique, class balance, and 
reference baseline as they all significantly affected 
classification performance. In his trial, SMV outperformed 
Naives Bayes by AUC of 0.82 versus 0.71. 
Investigations into biomarkers in NEC have found that 
pairing clinical features with biomarkers can significantly 
improve predictive value. Classifying each case on clinical 
findings and validated biomarkers using Linear Discriminant 
Analysis (LDA) in an ensemble model, Sylvester et al. 2014, 
estimated the predictive value of three urine peptide 
biomarkers. He found modelling biomarker panel alone 
yielded an AUC of  0.858. Clinical parameters alone had an 
AUC of 0.817 and left 40.1% of all patients in an 
‘indeterminate’ risk group. Once three UPD parameters 
(fibrinogen peptides: FGA1883, FGA1826 and FGA2659) 
where added to the clinical model the AUC increased as high 
as 0.856. Illustrating a popular approach in biomarker 
research, to improve accuracy by incorporating a 
combination of various biomarkers and clinical findings. 
Reisinger et al, also studying biomarkers in NEC, found 
improved diagnostic accuracy of combining serum amyloid 
A and faecal calprotectin with intestinal fatty acid-binding 
protein. Accuracy improved when both faecal calprotectin 
and I-FABP where combined (sensitivity 94%, specificity 
79%). As various biomarkers [10] are being investigated for 
various outcomes in NEC it would be advisable to create 
more sophisticated  ensemble models to combine clinical and 
biomarker data to ease the interpretation for clinical practice.   
Ensemble modelling can also test if prognostic variables 
are associated with a condition. This is especially useful in 
NEC as new biomarker combination, and imaging modalities 
(aka features) are being explored. Habibi et al. 2016 
compared the use of Artificial Neural Networks (ANN MLP) 
versus Linear regression (LR) in ensemble models, in 
extracting prognostic factors and diagnose shunt infections 
using clinical information. ANN outperformed LR models in 
predicting shunt infection with an accuracy of 83.1 % (AUC; 
91.98%, 95% CI and p<0.001) and 55.7% (AUC; 76.5, 95% 
CI). ANN showed five prognostic features including 
gestational age,  weight,  first shunt actual age, shunt 
revision, and myelomeningocele was significantly associated 
with shunt infection [11]. 
The predictive modelling needs for the clinical 
parameters of NEC would need a more dynamic and intuitive 
model. There are currently various assessment tools that have 
been developed to aid in the diagnosis of NEC [2], [12], [13] 
but these need to be comparatively tested in various settings 
to give a fair assessment of their performance. This would be 
useful to integrate into an ensemble model. An excellent 
example of such a model is the intelligent Jaundice diagnosis 
tool [21]. Hao et al. 2017, created an ensemble ‘Jaundice’ 
model using dynamic uncertain causality graph “chaining” 
inference algorithm and weighted logic operational flow for 
diagnostic reasoning. His model was able to integrate a 
diverse set of clinical features and their cut-off points. 
‘Jaundice’ model achieved an accuracy of 99.01% and 
84.73%. The results had a better pattern of logic and were 
easier to interpret than conventional methods such as 
Bayesian Networks, providing more objectivity. This 
illustrates the potential use of a more sophisticated system 
suitable for NEC diagnosis. 
Another sophisticated model is the three-dimensional 
mathematical and computational model of necrotising 
enterocolitis by Barber et al. 2013 [15]. This model shows 
great promise in advancing insights into pathophysiology. 
Unlike other ensemble models based on ordinary differential 
equations, their mathematic model considered both transient 
and spatial effects. Using cell-focussed fixed characteristics 
and a definitive Euler method, a structure of nonlinear 
transitionary sectional differential equations can be solved 
mathematically. The system monitors the evolution of an 
initial event (trauma) spatially in the intestinal wall. This 
model can provide an alternative or adjunct to animal trials 
to better explain the pathophysiological cascade of events. 
This will be particularly important when testing therapies 
and delineating various types of ANID.  
III. GAINING INSIGHTS THROUGH STANDARDISED CAD 
IMAGING AND PREDICTIVE MODELING OF FEATURES 
The timely diagnosis and monitoring is an important 
focus area for current research as it can improve outcomes in 
NEC [2]. In current practice, the diagnostic differentiation of 
SIP and NEC is based on clinical presentation, laboratory 
tests and imaging. The diagnosis of NEC strongly relies on 
imaging, as it provides an objective measurement to move 
beyond suspected NEC (suggestive clinical findings) to 
medically confirmed NEC, imaging of Portal Venous Gas 
(PVG) or Pneumatosis Intestinalis (PI). 
Abdominal radiographs were the standard gold imaging 
for visualising pathognomonic signs of NEC. Recently, two 
new non-invasive imaging modalities have shown promise in 
NEC, Abdominal ultra-sound (AUS) and broadband optical 
spectroscopy (BOS). The challenge in neonatology is great 
inter-expert variability in interpreting findings. This is 
mainly in AUS as it is a newer modality without guidelines 
in NEC. CAD can be a crucial enabler to overcome these 
challenges in adapting newer non-invasive imaging 
modalities. Since 1960's CAD has contributed significantly 
in AUS diagnostics. The first AUS CAD system was applied 
in the diagnosis of breast tumours [16]. CAD demonstrated 
improved the accuracy of diagnosis, reduced the time 
consumption, and decreases workload doctors [17]. Not 
surprisingly as the system enables guided assessment, rapid 
data processing, predictive analytic insights and enabled peer 
consensus from the clinician and radiologists [18]. 
A. Challenges and opportunities for AUS 
The challenge in using AUS in ML is acquiring a 
standard plane (for feature extraction and classification), to 
then in turn define the diagnostic plane (for evaluation of 
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changes and detection of pathognomonic findings). With 
radiology fellows, sonographers and clinicians this technique 
needs an experienced examiner. This very time-consuming 
even for experienced examiners and challenging for training 
fellows to master. Because the use of AUS in ANID (NEC) 
is new; finding experienced examiners is challenging, and 
with no standard guidelines we can expect the quality of 
insights to vary. Hence CAD has a critical role in integrating 
AUS in clinical practice, which in turn generates real-world 
data for validation of AUS in diagnostic criteria for various 
ANID’s [19]. 
The benefits of deep learning (DL) is it can detect both a 
ultrasound standard plane and sonographic diagnostic plane 
automatically. The sonographic diagnostic plane can enable 
the detection of epithelial changes (thickening, thinning or 
perforation) and detect anomalies. Yaqub et al. 2017, showed 
that CNN can automatically detect a foetal neuro-
sonographic diagnostic plane [20]. If the traditional method 
of feature input is used, then NEC AUS features as described 
by Faingold et al.2005 [21], Epelman et al. 2007 [22], 
Muchantef et al. 2013 [23], Bohnhorst et al. 2013 [24], Cuna 
et al. 2018 [25], [41], [42] should be considered to define the 
full breadth of textural and morphologic features. 
Techniques for feature input or extraction of AUS differ 
between organ systems needing examination by their 
respective conditions. This also shows considerable 
variability in accuracy between organ systems rather than 
traditional versus DL techniques. This suggests that in 
developing an NEC AUS CAD, both traditional and DL 
systems need to be comparatively analysed to find the best 
accuracy. Textural features are the most commonly used for 
traditional feature input and are often combined with 
morphologic features. The classifying techniques often 
combined with supervised models are: SVM,  ANN, FCN, 
decision trees and AdaBoost. 
Recently, Ni et al. 2014, successfully developed an ML 
technique to acquire a standard plane in AUS in infants.  In 
his study, he used a hierarchical, supervised learning 
framework to determine the standard plane from successive 
two-dimensional ultrasound images. The stomach bubble, 
umbilical vein and spine formed the critical anatomical co-
ordinates for the standard plane in the ultrasound video. A 
radial component-based model was used to describe the 
spatial limits of these anatomical coordinates and novel 
discriminatory search approach too advantage of the vessel 
probability algorithm to estimate the likelihood of the 
vicinity of the spine and umbilical vein. Results from 223 
new-born abdominal videos show it significantly 
outperformed total abdomen and other anatomy tracking 
software without spatial restrictions; the overall detection 
accuracy was 85.6% [28]. 
These results are at the lower range in comparison to 
other AUS CAD traditional techniques and DL. Hence it 
would be worth doing comparative trials using DL 
techniques such as GoogLeNet [29], [30], Boltzmann 
machine [31], Convolutional layers (CNN) [32], [33], Sparse 
encoder [34] and stacked denoising autoencoder (SDAE) 
[35] using his AUS standard plane from three key anatomical 
structures. To optimise accuracy other DL methods can be 
comparatively tested, for example looking at results from 
thyroid ultrasound models, accuracy was as high as 98.86-
99.13% for GoogLeNet [29] and CNN [32] respectively. 
Whilst using traditional textural feature input with 
classification techniques using either SVM [36], FCN [37], 
decision tree’s [38], ANN [39], or AdaBoost [40], we may 
see accuracy improve to 88.8 - 93,3 - 94,3- 98, and 100% 
respectively.  
IV. CLINICAL AND IMAGING PREDICTIVE MODEL FOR NEC 
A. Combined clinical and predictive imaging model  
Figure 2 shows combined traditional CAD and deep 
learning models for feature extraction and classification. 
Majority voting is used to choose the highest accuracy from 
the best combination of features and ML techniques. Once 
the best model for each of the sections, clinical and, is 
determined this will form the collective disease model by 
combination to try and further improve the accuracy of the 
case definition and find differential features to build each 
entity of ANIDS.  
FIGURE 2: PROPOSED COLLECTIVE DISEASE MODEL FOR NEC. 
 
 
 
V. FUTURE RECOMMENDATIONS AND CONCLUSION 
Clinical research as a whole, have a significant challenge 
ahead. The current set-up costs of once-off trials are causing 
a trajectory of costs that are unsustainable. Also, as our 
understanding improves we realise that the complexity of 
conditions is making it less likely to obtain answers through 
these traditional trials. A breakthrough in insight into the 
pathogenesis of some NEC subtypes or NEC mimickers may 
transform the NEC landscape. However, currently, we do not 
know if and when that moment will be. Integrating the 
capabilities of advanced data analytic technologies such as 
machine learning and CAD yields ongoing insights that can 
significantly improve clinical practice. The administration, 
integration, analysis and big data demands of such an 
understanding will be demanding, but it is an investment that 
will yield ongoing returns, not only in early diagnosis but 
continuous evaluation of newer modalities of treatment 
The current pace of change and the surmounting 
challenge to advance not only NEC research but to build case 
definition of every ANID entity will require a faster pace of 
adaptation to accommodate personalised medicine. Bedside 
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practice in neonatal units needs to be adaptable to embrace 
new technology to improve productivity, accuracy, and data 
collection. Predictive modelling holds great promise to 
advance NEC research and diagnostics. CAD can be the 
critical enabler to not only save time, resources and cost of 
research but can also help capture uniform, more productive 
and dynamic data to improve databases. The big data 
potential of this is substantial, but careful consideration must 
be made by neonatal networks to place an international data 
strategy in place to reap future rewards. 
Thorough planning should ensure that the integration of 
guidelines and regulations in clinical trials design are met. 
As predictive models are receiving more attention from 
regulators, failing to meet the requirements will jeopardise 
efforts. Currently, in Europe, the Standards for Reporting 
Diagnostic Accuracy Studies (STARD 2015) guidelines 
define these needs. For multivariate modelling TRIPOD 
guidelines stipulate standard measures of accuracy as well as 
transparent reporting for diagnostic model trials. There 
should be careful consideration of terminology, as defined by 
FDA BEST, when reporting on the model and their 
outcomes. As this is a rapidly evolving field, new 
publications from these regulatory bodies should be carefully 
monitored for updates.  
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